Kaishang Zhang

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Neoadjuvant therapy for NSCLC: From monotherapy to precision combination therapy.

Neoadjuvant therapy for NSCLC: From monotherapy to precision combination therapy.

Journal: Critical reviews in oncology/hematology
Published: April 30, 2026

Establishment and validation of a novel anoikis-related prognostic signature of lung squamous cell carcinoma.

Establishment and validation of a novel anoikis-related prognostic signature of lung squamous cell carcinoma.

Journal: Translational cancer research
Published: November 09, 2025

Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R-Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression.

Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R-Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 25, 2025

SDCBP2 promotes tumor progression and is a novel ferroptosis-related prognostic biomarker in lung adenocarcinoma.

SDCBP2 promotes tumor progression and is a novel ferroptosis-related prognostic biomarker in lung adenocarcinoma.

Journal: Frontiers in immunology
Published: September 04, 2025

Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy.

Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy.

Journal: BMC cancer
Published: May 09, 2025

Recurrence patterns and prognosis of esophageal cancer patients based on the Rbr resection status.

Recurrence patterns and prognosis of esophageal cancer patients based on the Rbr resection status.

Journal: Frontiers in oncology
Published: April 24, 2025

Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release.

Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release.

Journal: Oncogenesis
Published: September 05, 2022

miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.

miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.

Journal: Artificial cells, nanomedicine, and biotechnology
Published: July 03, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026